通过阿波利波蛋白A4减轻高脂肪饮食诱导的体重增加
Hsuan-Chih N Kuo1,2, Zachary LaRussa1,2, Flora Mengyang Xu3
1Department of Biomedical Sciences and Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.
Obesity (Silver Spring, Md.)
|November 14, 2024
概括
外源的阿波利波蛋白A4 (APOA4) 预防肥胖并改善高脂肪饮食小鼠的葡萄糖耐受性. APOA4增强了能量消耗和棕色脂肪组织热生成.
科学领域:
- 代谢和内分泌学
- 肥胖问题研究研究
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 脂蛋白A4 (APOA4) 是由小肠产生,以应对饮食中的脂质.
- 高脂肪饮食 (HFD) 损害了脂质诱导的APOA4的产生,并减少了棕色脂肪组织 (BAT) 的热生成.
- 这项研究调查了外源APOA4对抗HFD诱导的代谢功能障碍的潜力.
研究的目的:
- 为了确定外源APOA4的管理是否可以增强BAT热生成和HFD养小鼠的能源消耗.
- 评估APOA4对肥胖小鼠的身体组成,葡萄糖耐受性和肝脏健康的影响.
- 研究APOA4对包括脂肪酸氧化和脂质生成在内的代谢途径的影响.
主要方法:
- 在过去的4周内,小鼠接受了10周的HFD和持续的APOA4输液.
- 在BAT和部白脂肪组织 (IWAT) 中测量了热生成,使用红外成像.
- 使用各种技术评估身体组成,能量消耗,葡萄糖耐受性和肝脏肥胖症,包括定量核磁共振和生化分析.
主要成果:
- 在HFD养的小鼠中,APOA4输液防止了进一步的体重增加和脂肪量减少.
- 热生成在BAT和IWAT中,以及整体能源支出,被APOA4.A显著增强.
- APOA4治疗改善了葡萄糖耐受性,增加了肝脏脂肪酸氧化,并减少了肝脏脂质积累和脂肪.
结论:
- 通过外部给药来维持血APOA4水平有效地增加了BAT和IWAT热生成.
- APOA4促进肝脂肪酸氧化和整体能量消耗,防止HFD养小鼠的肥胖进展.
- 外源APOA4在饮食诱导的肥胖模型中具有治疗肥胖管理和改善代谢健康的治疗潜力.
相关概念视频
Regulation of Food Intake
193
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
193
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
538
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
538


